These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20341381)

  • 1. An explosive reaction following the simultaneous administration of sodium arsenite and dithioglycerol (BAL) in vivo.
    KOPPANYI T; SPERLING F
    Anat Rec; 1946 Dec; 96(4):501. PubMed ID: 20341381
    [No Abstract]   [Full Text] [Related]  

  • 2. Central and autonomic effects following the combined administration of sodium arsenite and 2,3-dimercaptopropanol (BAL).
    KOPPANYI T; SPERLING F
    J Pharmacol Exp Ther; 1947 Apr; 89(4):350-5. PubMed ID: 20295515
    [No Abstract]   [Full Text] [Related]  

  • 3. DMSA, DMPS, and DMPA--as arsenic antidotes.
    Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration by BAL (2,3-dimercapto-1-propanol) and DMPS (sodium 2,3-dimercapto-1-propanesulfonic acid) of arsenite developmental toxicity in mice.
    Domingo JL; Bosque MA; Llobet JM; Corbella J
    Ecotoxicol Environ Saf; 1992 Jun; 23(3):274-81. PubMed ID: 1376232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the body burden of arsenic in a child fatally poisoned by arsenite weedkiller.
    Saady JJ; Blanke RV; Poklis A
    J Anal Toxicol; 1989; 13(5):310-2. PubMed ID: 2615344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
    LUETSCHER JA; EAGLE H; LONG-COPE WT
    J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
    LONGCOPE WT; LUETSCHER JA
    J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
    [No Abstract]   [Full Text] [Related]  

  • 8. Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.
    Afolabi OK; Wusu AD; Ogunrinola OO; Abam EO; Babayemi DO; Dosumu OA; Onunkwor OB; Balogun EA; Odukoya OO; Ademuyiwa O
    BMC Pharmacol Toxicol; 2015 Jun; 16():15. PubMed ID: 26044777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact sensitivity to arsenical compounds. Clinical and experimental studies.
    Wahlberg JE; Boman A
    Derm Beruf Umwelt; 1986; 34(1):10-2. PubMed ID: 2937622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAL as an antidote to poisoning with sodium arsenite in sheep.
    WHITE IG; BLOOD DC; WHITTEM JH
    Aust Vet J; 1949 Jan; 25(1):8-11. PubMed ID: 18113385
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative acute systemic toxicity of sodium arsenite and dichloro(2-chlorovinyl)arsine in rabbits.
    Inns RH; Bright JE; Marrs TC
    Toxicology; 1988 Oct; 51(2-3):213-22. PubMed ID: 3176029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass poisoning by sodium arsenite.
    Roses OE; García Fernández JC; Villaamil EC; Camussa N; Minetti SA; Martínez de Marco M; Quiroga PN; Rattay P; Sassone A; Valle G
    J Toxicol Clin Toxicol; 1991; 29(2):209-13. PubMed ID: 2051508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of three antidotes on arsenic toxicity in the common earthworm (Lumbricus terrestris).
    Li W; Chien PK; Furst A
    J Appl Toxicol; 1994; 14(3):181-3. PubMed ID: 7521893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium.
    Suzuki S; Arnold LL; Pennington KL; Chen B; Naranmandura H; Le XC; Cohen SM
    Toxicol Appl Pharmacol; 2010 Apr; 244(2):99-105. PubMed ID: 20045014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms.
    Sakurai T; Kaise T; Matsubara C
    Chem Res Toxicol; 1998 Apr; 11(4):273-83. PubMed ID: 9548797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenite as the probable active species in the human carcinogenicity of arsenic: mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler's solution.
    Tinwell H; Stephens SC; Ashby J
    Environ Health Perspect; 1991 Nov; 95():205-10. PubMed ID: 1821373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous pigmentation in spots; arsenical poisoning? Sensitivity of the skin to sodium arsenite].
    CARPENTIER E
    Arch Belg Dermatol Syphiligr; 1951 Sep; 7(3):154-5. PubMed ID: 14915515
    [No Abstract]   [Full Text] [Related]  

  • 18. Optical isomers of 2,3-dimercapto-1-propanesulfonate: antidotal activity, in vitro and in vivo, against sodium arsenite.
    Hsu CA; Aposhian HV; Heydolph S; Parr W
    J Pharmacol Exp Ther; 1983 Feb; 224(2):314-8. PubMed ID: 6687396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arsenical erythroma extinguished by B.A.L. and sodium thiosulfate].
    SMITH H
    Union Med Can; 1949 Dec; 78(12):1437. PubMed ID: 15394898
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.